1. Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment
   Cassidy M. Van Stiphout et al, 2022, Cancers CrossRef
2. Unfolded Protein Response–Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma
   Zhao Zhang et al, 2022, Frontiers in Genetics CrossRef
3. Proteomic profiling and identification of significant markers from high-grade osteosarcoma after cryotherapy and irradiation
   Rashmi Madda et al, 2020, Scientific Reports CrossRef
4. Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle
   Anita K. Luu et al, 2022, International Journal of Molecular Sciences CrossRef
5. Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction
   Nutnicha Sirikaew et al, 2022, International Journal of Molecular Sciences CrossRef
6. Quantitative proteomic studies addressing unmet clinical needs in sarcoma
   Elizabeth A. Connolly et al, 2023, Frontiers in Oncology CrossRef
7. Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease
   Adriene Pavek et al, 2021, Biomedicines CrossRef
8. Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma
   Staci L. Haney et al, 2023, Drug Development Research CrossRef
9. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
   Timothy M. Fan et al, 2020, Frontiers in Oncology CrossRef
10. A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma
    Lu Wan et al, 2022, International Journal of General Medicine CrossRef
11. Osteosarcoma and Metastasis
    Gaohong Sheng et al, 2021, Frontiers in Oncology CrossRef